EP1476184A4 - Adherence d'immunogenes et sa methode d'elaboration et d'utilisation - Google Patents

Adherence d'immunogenes et sa methode d'elaboration et d'utilisation

Info

Publication number
EP1476184A4
EP1476184A4 EP01994346A EP01994346A EP1476184A4 EP 1476184 A4 EP1476184 A4 EP 1476184A4 EP 01994346 A EP01994346 A EP 01994346A EP 01994346 A EP01994346 A EP 01994346A EP 1476184 A4 EP1476184 A4 EP 1476184A4
Authority
EP
European Patent Office
Prior art keywords
making
same
immunogen adherence
immunogen
adherence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01994346A
Other languages
German (de)
English (en)
Other versions
EP1476184A1 (fr
Inventor
Peter Nash
Donald L Robinson
John W Rosevear
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Camas Inc
Original Assignee
Camas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Camas Inc filed Critical Camas Inc
Publication of EP1476184A1 publication Critical patent/EP1476184A1/fr
Publication of EP1476184A4 publication Critical patent/EP1476184A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Peptides Or Proteins (AREA)
EP01994346A 2001-12-28 2001-12-28 Adherence d'immunogenes et sa methode d'elaboration et d'utilisation Withdrawn EP1476184A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2001/049588 WO2003061693A1 (fr) 2001-12-28 2001-12-28 Adherence d'immunogenes et sa methode d'elaboration et d'utilisation

Publications (2)

Publication Number Publication Date
EP1476184A1 EP1476184A1 (fr) 2004-11-17
EP1476184A4 true EP1476184A4 (fr) 2006-01-04

Family

ID=27608951

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01994346A Withdrawn EP1476184A4 (fr) 2001-12-28 2001-12-28 Adherence d'immunogenes et sa methode d'elaboration et d'utilisation

Country Status (8)

Country Link
EP (1) EP1476184A4 (fr)
JP (1) JP2006504393A (fr)
KR (1) KR20040096491A (fr)
CN (1) CN1543355A (fr)
AU (1) AU2002246753B8 (fr)
BR (1) BR0117062A (fr)
CA (1) CA2438698C (fr)
WO (1) WO2003061693A1 (fr)

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0225254A2 (fr) * 1985-11-25 1987-06-10 Ghen Corporation Substance contenant un anticorps spécifique à partir d'oeufs, méthode de production et son utilisation
US4748018A (en) * 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
WO1996030043A1 (fr) * 1995-03-24 1996-10-03 Ophidian Pharmaceuticals Traitement contre escherichia coli producteur de verotoxines
WO1998014209A1 (fr) * 1996-10-02 1998-04-09 Ovimmune, Inc. Administration orale d'anticorps a base de jaune d'oeuf de poule pour le traitement de maladies
US5741489A (en) * 1996-05-24 1998-04-21 Anitox Corporation Passively administered antibody that enhances feed conversion efficiency
US5753228A (en) * 1992-08-25 1998-05-19 Arizona Board Of Regents On Behalf Of The University Of Arizona Method of treating parasitosis by the enteral administration of hyperimmune hen egg yolk antibodies
EP0955061A1 (fr) * 1998-03-20 1999-11-10 Medipharm CZ, s.r.o. Produit oral pour la prévention et la thérapie des infections gastrointériques porcines
DE19910159A1 (de) * 1999-02-26 2000-09-14 Rosemarie Heis Spezifische lgY-Eidotterantikörper, ihre Gewinnung und ihre Verwendung
US6162441A (en) * 1999-12-15 2000-12-19 Republic Of Korea (Management: Rural Development Administration) Method for the production of anti-escherichia. coli O157 : H7 antibody
WO2001048018A1 (fr) * 1999-12-27 2001-07-05 University Of Manitoba Vaccins genetiques pour la production d'anticorps de jaune d'oeuf de poule diriges contre escherichia coli enterotoxinogene et d'autres pathogenes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5725873A (en) * 1996-07-22 1998-03-10 Wisconsin Alumni Research Foundation Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein
US6083500A (en) * 1997-10-06 2000-07-04 University Of Georgia Research Foundation, Inc. Biological control of food pathogens in livestock

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4748018A (en) * 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
EP0225254A2 (fr) * 1985-11-25 1987-06-10 Ghen Corporation Substance contenant un anticorps spécifique à partir d'oeufs, méthode de production et son utilisation
US5080895A (en) * 1985-11-25 1992-01-14 Ghen Corporation Specific antibody-containing substance from eggs and method of production and use thereof
US5080895B1 (en) * 1985-11-25 1998-03-10 Ghen Corp nd method of production and use thereof Specific antibody-containing substance from eggs a
US5753228A (en) * 1992-08-25 1998-05-19 Arizona Board Of Regents On Behalf Of The University Of Arizona Method of treating parasitosis by the enteral administration of hyperimmune hen egg yolk antibodies
WO1996030043A1 (fr) * 1995-03-24 1996-10-03 Ophidian Pharmaceuticals Traitement contre escherichia coli producteur de verotoxines
US5741489A (en) * 1996-05-24 1998-04-21 Anitox Corporation Passively administered antibody that enhances feed conversion efficiency
WO1998014209A1 (fr) * 1996-10-02 1998-04-09 Ovimmune, Inc. Administration orale d'anticorps a base de jaune d'oeuf de poule pour le traitement de maladies
EP0955061A1 (fr) * 1998-03-20 1999-11-10 Medipharm CZ, s.r.o. Produit oral pour la prévention et la thérapie des infections gastrointériques porcines
DE19910159A1 (de) * 1999-02-26 2000-09-14 Rosemarie Heis Spezifische lgY-Eidotterantikörper, ihre Gewinnung und ihre Verwendung
US6162441A (en) * 1999-12-15 2000-12-19 Republic Of Korea (Management: Rural Development Administration) Method for the production of anti-escherichia. coli O157 : H7 antibody
WO2001048018A1 (fr) * 1999-12-27 2001-07-05 University Of Manitoba Vaccins genetiques pour la production d'anticorps de jaune d'oeuf de poule diriges contre escherichia coli enterotoxinogene et d'autres pathogenes

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
See also references of WO03061693A1 *
XP009114736 *
XP009114761 *
XP009114762 *
YOKOYAMA H ET AL: "Passive protective effect of chicken egg yolk immunoglobulins against experimental enterotoxigenic Escherichia coli infection in neonatal piglets", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY. WASHINGTON, US, vol. 60, no. 3, March 1992 (1992-03-01), pages 998 - 1007, XP002109373, ISSN: 0019-9567 *

Also Published As

Publication number Publication date
CN1543355A (zh) 2004-11-03
AU2002246753B2 (en) 2009-05-28
BR0117062A (pt) 2005-12-13
WO2003061693A1 (fr) 2003-07-31
EP1476184A1 (fr) 2004-11-17
KR20040096491A (ko) 2004-11-16
AU2002246753B8 (en) 2009-09-24
JP2006504393A (ja) 2006-02-09
CA2438698A1 (fr) 2003-07-31
AU2002246753A1 (en) 2003-09-02
CA2438698C (fr) 2013-12-17

Similar Documents

Publication Publication Date Title
AU2002364528A8 (en) Bio-implant and method of making the same
IL200255A (en) Method of preparing o-desmethyl-venlafaxine
GB0415646D0 (en) Waveguide and method of manufacture
HK1065978A1 (en) Condrapable hydrophobic nonwoven and method of making same
AU2001261160A1 (en) Prosthesis and method of making
PL357927A1 (en) Method of obtaining trimethylpropane
PL353633A1 (en) Method of obtaining derivatives of 4"-substituted-9-deoxy-9a-aza-9a-homoerythromycin
PL355161A1 (en) Method of manufacture
IL160835A0 (en) Catheter and method of using same
IL157609A0 (en) A vaccine composition and method of using the same
HK1046646A1 (zh) 製劑和生產該製劑的方法
GB2390505B (en) Loudspeaker and method of making same
GB2389602B (en) Cover and method of making same
GB0113869D0 (en) Plaster composition and method of making the same
GB0400117D0 (en) Microelctronic device and method of its manufacture
EP1476184A4 (fr) Adherence d'immunogenes et sa methode d'elaboration et d'utilisation
AU2002337649A8 (en) Method of making fgf-12 and kgf-2
PL351128A1 (en) Method of obtaining phenoglycine and derivatives thereof
SI1216975T1 (en) Coated ceramic parts and method of fabricating same
EP1435953A4 (fr) Composes antivesicants et procedes de fabrication et d'utilisation associes
EP1362193A4 (fr) Cheville et procede d'utilisation
AU8626801A (en) Method of forming complex
PL356317A1 (en) Method of obtaining alkanosulphonylpyridines
PL343141A1 (en) Novel silylcarbamates and method of obtaining them
GB0114504D0 (en) Plaster composition and method of making the same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040617

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1073425

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20051118

17Q First examination report despatched

Effective date: 20060201

17Q First examination report despatched

Effective date: 20060201

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090701

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1073425

Country of ref document: HK